Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.
about
The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cellsMicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cellsMembrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cellsGraviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolismMUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cellsStructure, evolution, and biology of the MUC4 mucinMucins in cancer: function, prognosis and therapyEpidermal growth factor mediates detachment from and invasion through collagen I and Matrigel in Capan-1 pancreatic cancer cellsGastrointestinal effects of Nigella sativa and its main constituent, thymoquinone: a reviewMucin-based targeted pancreatic cancer therapyMucins in neoplasms of pancreas, ampulla of Vater and biliary systemHonokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cellsNovel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapyAmyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis.Genomic and transcriptomic characterization of skull base chordoma.Pathogenesis of ovarian cancer: clues from selected overexpressed genes.Muc4/MUC4 functions and regulation in cancerOncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia.The traditional Chinese medicine Achyranthes bidentata and our de novo conception of its metastatic chemoprevention: from phytochemistry to pharmacology.MUC13 mucin augments pancreatic tumorigenesis.The dynamic exome: acquired variants as individuals age.High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasisMUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progeniesRNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cellsEffects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapiesMonoclonal antibodies recognizing the non-tandem repeat regions of the human mucin MUC4 in pancreatic cancer.Pathobiological implications of MUC16 expression in pancreatic cancer.Upregulation of MUC4 in cervical squamous cell carcinoma: pathologic significance.Nicotine and oxidative stress induced exomic variations are concordant and overrepresented in cancer-associated genesNucleotide variability and linkage disequilibrium patterns in the porcine MUC4 gene.CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapyMUC4 regulates cellular senescence in head and neck squamous cell carcinoma through p16/Rb pathway.MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells.The molecular targets for the diagnosis and treatment of pancreatic cancer.Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer.MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expressionCharacterization of human mucin MUC17. Complete coding sequence and organization.Specific-detection of clinical samples, systematic functional investigations, and transcriptome analysis reveals that splice variant MUC4/Y contributes to the malignant progression of pancreatic cancer by triggering malignancy-related positive feedbPancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreasMUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells.
P2860
Q24528155-3869D430-3156-402E-8F08-3A6C5CC5D400Q24596316-3EE90B0C-4266-4C1F-A5F4-D22F087EA15EQ24601584-A9A6081D-7787-4EF9-8DD8-D368E02604FAQ24608066-C270CE89-311E-4642-8CEA-AC2214D29BF0Q24630950-1D52A1B9-4308-4F76-86E4-847F14503BB7Q24630985-65A3329B-A67A-4FB0-9008-28A0BD0EEFAEQ24633765-2361EDFF-125E-48B4-9DC2-A3249BA43292Q24792963-12EFE2BC-B8AB-4A79-BA7F-03E96FAB2CDCQ26744253-A4EA64C3-462A-47DC-B434-DBE448B4A9AEQ26861761-C944EE76-5EAA-4F21-99BF-380EAD24C26BQ28070355-2C8FC77A-7258-4452-8325-566DB38F0FE8Q28478749-10EF77B6-CA1B-4DEC-BE4E-E17F81043952Q28535288-04911850-BEB6-4404-AA43-C2F7FF32F631Q30300982-5773699C-3F84-40D2-B433-7876DAFEACB7Q33276293-1F9E5F51-F7C6-4946-9E7A-A85AAEDCBFB5Q33651139-E9193CB2-FE28-447C-A8A7-4FA83151A102Q33674729-79724EA9-8D84-419A-895C-DD156190598EQ33810570-E4AED2FF-A0BE-426E-A9B8-030FCC7ED2C8Q33819016-8E0D19F7-A546-4762-B975-8243AEB322CCQ33909073-7DB4651C-FC9E-464B-856E-5E13F398C626Q33910495-72669832-C4D6-470A-978B-AAB5BBED20A6Q33926378-9FE9E18F-09B4-4276-8232-CEE72A68D885Q33938044-1DD54455-7D75-4A3F-9D67-FF953CF878E1Q33946423-884A7D5D-3587-482F-A2F9-29B9B76AD746Q34003722-B7C2639C-B941-4B5F-A51B-A7E4B2DD50EEQ34008828-E399E7A7-6FEC-49D5-B8D6-DCF5BC8F23F6Q34069612-D290C535-9153-4B14-A624-0E6E6586B473Q34099890-17166710-6D11-4927-A950-D6DACFF2CDBDQ34104036-5ABDB3AD-C962-455D-8814-D78B3EB36C4CQ34336892-2ECDD028-30B7-40D4-A214-F3C07E1C8D2AQ34363535-A0A358F3-F7E0-4C79-85F5-7CFAB51E5CFDQ34381590-13673CE9-164C-47D8-95D6-76A981909389Q34423709-078B20DE-FAED-4C3B-8119-26474B3BA425Q34494019-751EE1FF-3BDF-48BC-991E-40A5E1E6ED66Q34500864-6BC2D0B0-681E-4FCC-A154-115A484F64FEQ34524741-9849894C-DADF-41C1-BFB4-F667AB285BBCQ34532428-34C31CCF-41B4-495B-BD82-BD716C06BC6AQ34537320-F28CAC6B-4F6B-444E-AE74-CD5B4D9F084EQ34560967-57938D41-E59E-4929-9843-BFADFD6DD21CQ34585874-C4FDC1BE-5794-4FD2-A2E7-6336BBF06BAD
P2860
Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.
@ast
Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.
@en
Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.
@nl
type
label
Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.
@ast
Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.
@en
Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.
@nl
prefLabel
Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.
@ast
Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.
@en
Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.
@nl
P2093
P1433
P1476
Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis
@en
P2093
Jane L Meza
Subhash C Chauhan
Surinder K Batra
P304
P356
10.1158/0008-5472.CAN-03-2636
P407
P577
2004-01-01T00:00:00Z